ES2572388T3 - Heterodímeros del MHC de clase II solubles funcionales estabilizados por enlaces disulfuro - Google Patents
Heterodímeros del MHC de clase II solubles funcionales estabilizados por enlaces disulfuroInfo
- Publication number
- ES2572388T3 ES2572388T3 ES11730044T ES11730044T ES2572388T3 ES 2572388 T3 ES2572388 T3 ES 2572388T3 ES 11730044 T ES11730044 T ES 11730044T ES 11730044 T ES11730044 T ES 11730044T ES 2572388 T3 ES2572388 T3 ES 2572388T3
- Authority
- ES
- Spain
- Prior art keywords
- mhc
- heterodimers
- stabilized
- chain
- disulfide bonds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000043131 MHC class II family Human genes 0.000 abstract 2
- 108091054438 MHC class II family Proteins 0.000 abstract 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 abstract 2
- 102000018713 Histocompatibility Antigens Class II Human genes 0.000 abstract 1
- 108010027412 Histocompatibility Antigens Class II Proteins 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30572810P | 2010-02-18 | 2010-02-18 | |
| GBGB1002730.8A GB201002730D0 (en) | 2010-02-18 | 2010-02-18 | Product |
| US31657610P | 2010-03-23 | 2010-03-23 | |
| PCT/GB2011/050325 WO2011101681A2 (en) | 2010-02-18 | 2011-02-18 | Disulphide bond-stabilized functional soluble mhc class ii heterodimers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2572388T3 true ES2572388T3 (es) | 2016-05-31 |
Family
ID=42113985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES11730044T Active ES2572388T3 (es) | 2010-02-18 | 2011-02-18 | Heterodímeros del MHC de clase II solubles funcionales estabilizados por enlaces disulfuro |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8828379B2 (el) |
| EP (1) | EP2536746B1 (el) |
| JP (1) | JP5537675B2 (el) |
| KR (1) | KR101647176B1 (el) |
| CN (1) | CN102947330B (el) |
| AU (1) | AU2011217027B2 (el) |
| CA (1) | CA2789492C (el) |
| CY (1) | CY1117697T1 (el) |
| DK (1) | DK2536746T3 (el) |
| ES (1) | ES2572388T3 (el) |
| GB (1) | GB201002730D0 (el) |
| HR (1) | HRP20160475T1 (el) |
| HU (1) | HUE027952T2 (el) |
| PL (1) | PL2536746T3 (el) |
| RS (1) | RS54744B1 (el) |
| RU (1) | RU2604813C2 (el) |
| SI (1) | SI2536746T1 (el) |
| WO (1) | WO2011101681A2 (el) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201309469D0 (en) | 2013-05-28 | 2013-07-10 | Imcyse Sa | Detection of CD4+ T lymphocytes |
| RU2732148C2 (ru) * | 2014-07-09 | 2020-09-11 | Люпин Лимитед | Двухцистронная бактериальная система экспрессии |
| US11059880B2 (en) | 2015-06-30 | 2021-07-13 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Redirected cells with MHC chimeric receptors and methods of use in immunotherapy |
| MA45489A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés de culture de cellules, kits et appareil associés |
| US10294454B2 (en) | 2016-08-24 | 2019-05-21 | General Electric Company | Methods and kits for cell activation |
| EP3538559A4 (en) * | 2016-11-09 | 2020-06-24 | UTI Limited Partnership | RECOMBINANT PMHC CLASS II MOLECULES |
| AR111625A1 (es) | 2017-04-27 | 2019-07-31 | Juno Therapeutics Gmbh | Reactivos de partículas oligoméricas y métodos de uso de los mismos |
| DE102018122546B3 (de) | 2018-09-14 | 2019-12-05 | Immatics Biotechnologies Gmbh | Verfahren zum Hochdurchsatz-Peptid-MHC-Affinitätsscreening für TCR-Liganden |
| CN113366311A (zh) * | 2018-09-28 | 2021-09-07 | 丹麦技术大学 | 使用可加载的检测分子的高通量表位鉴定和t细胞受体特异性测定 |
| TW202043256A (zh) | 2019-01-10 | 2020-12-01 | 美商健生生物科技公司 | 前列腺新抗原及其用途 |
| EP3719033A1 (en) * | 2019-04-02 | 2020-10-07 | imusyn GmbH & Co. KG | Stabilized mhc i |
| WO2021035049A1 (en) * | 2019-08-21 | 2021-02-25 | Uti Limited Partnership | Improved recombinant pmhc molecules |
| EP4028412A2 (en) * | 2019-09-13 | 2022-07-20 | The Regents of The University of California | Systems and methods for the preparation of peptide-mhc-i complexes with native glycan modifications |
| WO2021113297A1 (en) * | 2019-12-02 | 2021-06-10 | Regeneron Pharmaceuticals, Inc. | Peptide-mhc ii protein constructs and uses thereof |
| TW202144389A (zh) | 2020-02-14 | 2021-12-01 | 美商健生生物科技公司 | 在多發性骨髓瘤中表現之新抗原及其用途 |
| TW202144388A (zh) | 2020-02-14 | 2021-12-01 | 美商健生生物科技公司 | 在卵巢癌中表現之新抗原及其用途 |
| DE102020109447A1 (de) | 2020-04-03 | 2021-10-07 | Jacobs University Bremen Ggmbh | Synthetisches mhc-klasse-ii-protein |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990010457A1 (en) | 1989-03-14 | 1990-09-20 | New York University | Method of treating hiv infections using immunotoxins |
| EP0935607B1 (en) | 1996-08-16 | 2004-07-28 | The President And Fellows Of Harvard College | Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| US6270772B1 (en) * | 1997-09-16 | 2001-08-07 | Oregon Health Sciences University | Recombinant MHC molecules useful for manipulation of antigen-specific T-cells |
| ID28040A (id) * | 1998-05-19 | 2001-05-03 | Avidex Ltd | Reseptor sel t yang dapat larut |
| RU2303264C2 (ru) * | 2001-02-19 | 2007-07-20 | Мерк Патент Гмбх | Способ идентификации эпитопов т-клеток и его применение для получения молекул со сниженной иммуногенностью |
| GB2392158B (en) * | 2002-08-21 | 2005-02-16 | Proimmune Ltd | Chimeric MHC protein and oligomer thereof |
| EP3144011A1 (en) * | 2003-09-05 | 2017-03-22 | Oregon Health & Science University | Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells |
| CA2638892A1 (en) * | 2005-03-18 | 2006-09-28 | Oregon Health & Science University | Recombinant mhc molecules useful for manipulation of antigen-specific t cells |
| ES2657480T3 (es) * | 2006-08-11 | 2018-03-05 | Life Sciences Research Partners Vzw | Péptidos inmunogénicos y su uso en trastornos inmunitarios |
| JP5154564B2 (ja) * | 2006-12-01 | 2013-02-27 | カール・ツァイス・エスエムティー・ゲーエムベーハー | 像収差を低減するための交換可能で操作可能な補正構成を有する光学システム |
| EP2193199B1 (en) | 2007-08-20 | 2013-11-06 | Nextera AS | Pvii phage display |
-
2010
- 2010-02-18 GB GBGB1002730.8A patent/GB201002730D0/en not_active Ceased
-
2011
- 2011-02-18 KR KR1020127024287A patent/KR101647176B1/ko active IP Right Grant
- 2011-02-18 US US13/579,887 patent/US8828379B2/en active Active
- 2011-02-18 SI SI201130815A patent/SI2536746T1/sl unknown
- 2011-02-18 RU RU2012138302/10A patent/RU2604813C2/ru active
- 2011-02-18 WO PCT/GB2011/050325 patent/WO2011101681A2/en active Application Filing
- 2011-02-18 DK DK11730044.2T patent/DK2536746T3/en active
- 2011-02-18 ES ES11730044T patent/ES2572388T3/es active Active
- 2011-02-18 CN CN201180011237.4A patent/CN102947330B/zh active Active
- 2011-02-18 CA CA2789492A patent/CA2789492C/en active Active
- 2011-02-18 HU HUE11730044A patent/HUE027952T2/en unknown
- 2011-02-18 JP JP2012553409A patent/JP5537675B2/ja active Active
- 2011-02-18 RS RS20160323A patent/RS54744B1/sr unknown
- 2011-02-18 AU AU2011217027A patent/AU2011217027B2/en active Active
- 2011-02-18 PL PL11730044T patent/PL2536746T3/pl unknown
- 2011-02-18 EP EP11730044.2A patent/EP2536746B1/en active Active
-
2014
- 2014-07-14 US US14/331,014 patent/US9056920B2/en active Active
-
2016
- 2016-05-04 HR HRP20160475TT patent/HRP20160475T1/hr unknown
- 2016-05-11 CY CY20161100397T patent/CY1117697T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2789492A1 (en) | 2011-08-25 |
| US8828379B2 (en) | 2014-09-09 |
| CN102947330A (zh) | 2013-02-27 |
| DK2536746T3 (en) | 2016-05-30 |
| CN102947330B (zh) | 2015-09-16 |
| HUE027952T2 (en) | 2016-11-28 |
| PL2536746T3 (pl) | 2016-08-31 |
| RU2604813C2 (ru) | 2016-12-10 |
| CY1117697T1 (el) | 2017-05-17 |
| JP2013519721A (ja) | 2013-05-30 |
| KR101647176B1 (ko) | 2016-08-09 |
| US9056920B2 (en) | 2015-06-16 |
| CA2789492C (en) | 2017-04-18 |
| GB201002730D0 (en) | 2010-04-07 |
| AU2011217027B2 (en) | 2015-02-05 |
| SI2536746T1 (sl) | 2016-09-30 |
| US20130171668A1 (en) | 2013-07-04 |
| RU2012138302A (ru) | 2014-03-27 |
| EP2536746A2 (en) | 2012-12-26 |
| RS54744B1 (sr) | 2016-10-31 |
| KR20130009782A (ko) | 2013-01-23 |
| EP2536746B1 (en) | 2016-04-20 |
| US20140349315A1 (en) | 2014-11-27 |
| AU2011217027A1 (en) | 2012-09-06 |
| WO2011101681A2 (en) | 2011-08-25 |
| HRP20160475T1 (hr) | 2016-06-03 |
| WO2011101681A3 (en) | 2011-12-08 |
| JP5537675B2 (ja) | 2014-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2572388T3 (es) | Heterodímeros del MHC de clase II solubles funcionales estabilizados por enlaces disulfuro | |
| ES2512141T3 (es) | Análogo peptídico de oxintomodulina | |
| ES2528347T3 (es) | Derivado peptídico insulinotrópico en el que se ha modificado su aminoácido n-terminal | |
| CL2018003148A1 (es) | Proteínas de fusión y usos de las mismas. | |
| PE20190743A1 (es) | Metodos para el tratamiento de la atrofia muscular y enfermedad osea con el uso de proteinas trap hibridas novedosas del ligando actriib | |
| NI201300143A (es) | Coagonista del receptor de glucagón/glp-1 | |
| CR20120366A (es) | Proteínas de enlace a antigenos humanas que enlazan beta-klotho, receptores fgf y complejos de los mismos | |
| CL2014000400A1 (es) | Proteina de union al antigeno especifica para el heterodimero alfa4beta7; y composicion que la comprende (div.sol.n°2306-11). | |
| CY1115413T1 (el) | Ανασυνδυασμενη fsh η οποια περιλαμβανει αλφα 2,3- και αλφα 2',6-sialylation | |
| PE20171325A1 (es) | Polipeptidos del receptor de activina variante y uso de los mismos | |
| ME01136B (me) | Antitumorske kombinacije koje sadrže antitijela koja specifično prepoznaju cd38 i melfalan | |
| PE20120532A1 (es) | ANTICUERPOS ANTI-ActRIIB | |
| CL2012001722A1 (es) | Compuestos derivados de 3-hidroxi-5-arilisotiazol, agonistas del receptor 40 acoplado a la proteina g (gpr40); composición farmacéutica que los comprende; y método para el tratamiento o la prevención de la diabetes. | |
| MX2016007063A (es) | Peptidos terapeuticos. | |
| EA201591454A1 (ru) | Связывающие внеклеточный матрикс синтетические пептидогликаны | |
| PE20230404A1 (es) | Un conjugado que comprende oxintomodulina y un fragmento de inmunoglobulina, y uso del mismo | |
| PA8811501A1 (es) | Nuevos derivados de insulina con perfil tiempo/acción extremadamente retardado | |
| PE20121503A1 (es) | Estabilizacion de probioticos | |
| CO6351811A2 (es) | La proteina de tuberculosis rv2386c, composiciones y usos de la misma | |
| PE20121393A1 (es) | Analogo peptidico de oxintomodulina | |
| UA118558C2 (uk) | Пептидна сполука | |
| ES2585328T3 (es) | Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis | |
| EA201170242A1 (ru) | Модифицированные бычьи полипептиды g-csf и их применение | |
| BRPI0818288A2 (pt) | Proteínas conjugadas e peptídeos. | |
| CY1115140T1 (el) | Πεπτιδια και η χρηση τους |